Summary
Background
Evidence of whether people living with HIV are at elevated risk of adverse COVID-19 outcomes is inconclusive. We aimed to investigate this association using the population-based National COVID Cohort Collaborative (N3C) data in the USA.
Methods
We included all adult (aged ≥18 years) COVID-19 cases with any health-care encounter from 54 clinical sites in the USA, with data being deposited into the N3C. The outcomes were COVID-19 disease severity, hospitalisation, and mortality. Encounters in the same health-care system beginning on or after January 1, 2018, were also included to provide information about pre-existing health conditions (eg, comorbidities). Logistic regression models were employed to estimate the association of HIV infection and HIV markers (CD4 cell count, viral load) with hospitalisation, mortality, and clinical severity of COVID-19 (multinomial). The models were initially adjusted for demographic characteristics, then subsequently adjusted for smoking, obesity, and a broad range of comorbidities. Interaction terms were added to assess moderation effects by demographic characteristics.
Findings
In the harmonised N3C data release set from Jan 1, 2020, to May 8, 2021, there were 1 436 622 adult COVID-19 cases, of these, 13 170 individuals had HIV infection. A total of 26 130 COVID-19 related deaths occurred, with 445 among people with HIV. After adjusting for all the covariates, people with HIV had higher odds of COVID-19 death (adjusted odds ratio 1·29, 95% CI 1·16–1·44) and hospitalisation (1·20, 1·15–1·26), but lower odds of mild or moderate COVID-19 (0·61, 0·59–0·64) than people without HIV. Interaction terms revealed that the elevated odds were higher among older age groups, male, Black, African American, Hispanic, or Latinx adults. A lower CD4 cell count (<200 cells per μL) was associated with all the adverse COVID-19 outcomes, while viral suppression was only associated with reduced hospitalisation.
Interpretation
Given the COVID-19 pandemic's exacerbating effects on health inequities, public health and clinical communities must strengthen services and support to prevent aggravated COVID-19 outcomes among people with HIV, particularly for those with pronounced immunodeficiency.
Funding
National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.
【초록키워드】 COVID-19, public health, HIV, Infectious diseases, Mortality, COVID-19 pandemic, obesity, Comorbidities, immunodeficiency, risk, outcome, smoking, Moderate COVID-19, COVID, outcomes, Adults, Viral load, Regression model, male, Older age, death, Community, Mild, covariates, USA, information, hospitalisation, African American, funding, HIV infection, association, Hispanic, marker, Clinical severity, COVID-19 cases, health inequities, demographic characteristics, evidence of, Support, health-care system, black, adjusted odds ratio, 95% CI, COVID-19 case, individual, COVID-19 disease severity, center, finding, encounter, health condition, Latinx, Effect, Inconclusive, Prevent, Cell, health-care, occurred, elevated, reduced, adjusted, added, groups, with HIV, Advancing, CD4 cell, exacerbating, higher odd, people with HIV, 【제목키워드】 COVID, HIV infection, Analysis, population level,